Table of Contents Table of Contents
Previous Page  990 / 1119 Next Page
Information
Show Menu
Previous Page 990 / 1119 Next Page
Page Background

morbidity 3y ≥G3:

10%

3%

LC 3 y: 90%

OS 3 y:

IGABT/ChTh: 79%

NOCECA: 63%

Lindegaard et al.

Acta Oncologica 2013